Frank Rigo

Active 2007–2025

110
Papers
18,668
Citations
67
h-index
108
i10-index

Citations

Citations per year for Frank Rigo1994: 1 citations1995: 1 citations2008: 1 citations2009: 2 citations2010: 5 citations2011: 32 citations2012: 43 citations2013: 74 citations2014: 99 citations2015: 162 citations2016: 234 citations2017: 362 citations2018: 368 citations2019: 939 citations2020: 1,085 citations2021: 1,145 citations2022: 893 citations2023: 816 citations2024: 1,175 citations2025: 687 citations2026: 19 citations1996–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,867 citing papers, 32% of this breakdownChina: 901 citing papers, 10% of this breakdownUnited Kingdom: 714 citing papers, 8% of this breakdownGermany: 556 citing papers, 6.2% of this breakdownItaly: 372 citing papers, 4.1% of this breakdownCanada: 333 citing papers, 3.7% of this breakdownFrance: 282 citing papers, 3.1% of this breakdownAustralia: 257 citing papers, 2.9% of this breakdownJapan: 247 citing papers, 2.8% of this breakdownNetherlands: 236 citing papers, 2.6% of this breakdownSpain: 216 citing papers, 2.4% of this breakdownSwitzerland: 185 citing papers, 2.1% of this breakdown
0%32%Other 20.1%

Fields

  • Biochemistry, Genetics and Molecular Biology50%
  • Medicine38.2%
  • Neuroscience9.3%
  • Immunology and Microbiology1.1%
  • Engineering0.3%
  • Agricultural and Biological Sciences0.2%
  • Other0.9%

Topics

  • RNA Research and Splicing10.3%
  • RNA modifications and cancer8.6%
  • Neurogenetic and Muscular Disorders Research8%
  • Amyotrophic Lateral Sclerosis Research7.2%
  • Cancer-related molecular mechanisms research4%
  • RNA and protein synthesis mechanisms3.7%
  • Other58.2%

Coauthors

All papers

Open in search
  1. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)

    Authors: , , , , , , , , , , , , , - Nature Methods 2016 cited by 1,577

  2. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2019 cited by 667

  3. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 2023 cited by 247

  4. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice

    Authors: , , , , , , , , , , , , , - Nature 2017 cited by 593

  5. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

    Authors: , , , , , , , , , , , , , - The Lancet 2016 cited by 1,016

  6. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 196

  7. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pieter J. de Jong, Dieter Edbauer, Philip Van Damme, Leonard Petrucelli, Christopher E. Shaw, C. Frank Bennett, Sandrine Da Cruz, John Ravits, Frank Rigo, Don W. Cleveland, Clotilde Lagier‐Tourenne - Neuron 2016 cited by 540

  8. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model

    Authors: , , , , , , - Nature 2011 cited by 754

  9. Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Stergioulis, Raymond K. Tong, Hai L. Tran, Y. Joy Yu Zuchero, Anthony A. Estrada, Kapil Gadkar, Christopher M. Koth, Pascal E. Sanchez, Robert G. Thorne, Ryan J. Watts, Thomas Sandmann, Lesley A. Kane, Frank Rigo, Mark S. Dennis, Joseph W. Lewcock, Sarah L. DeVos - Science Translational Medicine 2024 cited by 119

  10. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport

    Authors: , , , , , , , , , , , , , - Cell 2018 cited by 442

  11. G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD

    Authors: , , , , , , , , , , , , , , - Neuron 2020 cited by 165

  12. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS

    Authors: , , , , , , , - Science Translational Medicine 2021 cited by 143

  13. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model

    Authors: , , , , , , - Genes & Development 2010 cited by 655

  14. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA

    Authors: , , , , , - Nature 2014 cited by 527

  15. Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 193

  16. Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood–brain barrier and knock down genes in the rodent CNS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2021 cited by 137

  17. ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth

    Authors: , , , , , , , , , , - Cancer Research 2021 cited by 117

  18. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 557

  19. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

    Authors: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2013 cited by 691

  20. Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2011 cited by 553

  21. The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration

    Authors: , , , , , , , , , , , , , - Nucleic Acids Research 2020 cited by 121

  22. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2024 cited by 70

  23. Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 75

  24. Antisense Reduction of Tau in Adult Mice Protects against Seizures

    Authors: , , , , , , , , , , , , , - Journal of Neuroscience 2013 cited by 312